LESLIE WOOD: Open Payments
NPI 1508282609 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 14 payments from 6 companies in 2025. Trend: 2023 $100 · 2024 $278 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 4 | $104 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| GENZYME CORPORATION | 2 | $46 |
| Optinose US, Inc. | 2 | $34 |
| Xeris Pharmaceuticals, Inc. | 1 | $28 |
| Hikma Pharmaceuticals USA | 1 | $16 |
Products named: DUPIXENT, NUCALA, Xhance, GVOKE HYPOPEN, Ryaltris.
Industry payments across LA — which companies pay providers there.
